Literature DB >> 19755920

Erdheim-Chester disease in childhood: a challenging diagnosis and treatment.

Tu-Anh Tran1, Monique Fabre, Daniele Pariente, Irina Craiu, Julien Haroche, Frederic Charlotte, Pierre Eid, Antoine Durrbach, Yassine Taoufik, Isabelle Kone-Paut.   

Abstract

Erdheim-Chester disease is a rare, non-Langerhans systemic histiocytosis characterized by bilateral sclerosis of the metaphyseal regions of the long bones and infiltration in other organs. The histopathologic hallmark is defined by a mononuclear infiltrate of foamy histiocytes and rare pathognomonic Touton giant cells with extensive fibrosis. This condition is exceptional in children. We report here a case of Erdheim-Chester disease in a 10-year-old girl with retroperitoneal infiltration and bone involvement, for whom the diagnosis was only established after a 3-year course with multiple biopsies. It is also the first pediatric case successfully treated with interferon-alpha suggesting that interferon-alpha can be a safe and efficient first-line therapy for this disease in children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755920     DOI: 10.1097/MPH.0b013e3181b76827

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  13 in total

Review 1.  Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature.

Authors:  Jose Emilio Sanchez; Carmen Mora; Manuel Macia; Juan F Navarro
Journal:  Int Urol Nephrol       Date:  2010-03-16       Impact factor: 2.370

Review 2.  Erdheim-Chester Disease: a comprehensive review of the literature.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Yehuda Shoenfeld
Journal:  Orphanet J Rare Dis       Date:  2013-09-08       Impact factor: 4.123

Review 3.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

4.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

Review 5.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

6.  Erdheim-Chester disease with multisystem involvement in a 4-year-old.

Authors:  Sook Yun Song; Sun Wha Lee; Kyung-Ha Ryu; Sun Hee Sung
Journal:  Pediatr Radiol       Date:  2011-08-31

Review 7.  Histiocytic disorders.

Authors:  Kenneth L McClain; Camille Bigenwald; Matthew Collin; Julien Haroche; Rebecca A Marsh; Miriam Merad; Jennifer Picarsic; Karina B Ribeiro; Carl E Allen
Journal:  Nat Rev Dis Primers       Date:  2021-10-07       Impact factor: 65.038

Review 8.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Fleur Cohen-Aubart; Baptiste Hervier; Frédéric Charlotte; Jean-François Emile; Zahir Amoura
Journal:  Curr Rheumatol Rep       Date:  2014-04       Impact factor: 4.592

9.  Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series.

Authors:  Roei D Mazor; Mirra Manevich-Mazor; Anat Kesler; Orna Aizenstein; Iris Eshed; Ronald Jaffe; Yakov Pessach; Ilan Goldberg; Eli Sprecher; Iris Yaish; Alexander Gural; Chezi Ganzel; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2014-12-01       Impact factor: 8.775

10.  Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Zsófia Váradi; Rita Bánusz; Judit Csomor; Krisztián Kállay; Edit Varga; Gabriella Kertész; Monika Csóka
Journal:  Onco Targets Ther       Date:  2017-01-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.